323 related articles for article (PubMed ID: 38349409)
1. Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers.
Ebrahimi R; Nasri F; Kalantari T
Ann Hematol; 2024 Jun; 103(6):1819-1831. PubMed ID: 38349409
[TBL] [Abstract][Full Text] [Related]
2. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.
Ng H; Havervall S; Rosell A; Aguilera K; Parv K; von Meijenfeldt FA; Lisman T; Mackman N; Thålin C; Phillipson M
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):988-994. PubMed ID: 33267662
[TBL] [Abstract][Full Text] [Related]
3. The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy.
Khezri MR; Varzandeh R; Ghasemnejad-Berenji M
Cell Mol Biol Lett; 2022 Jan; 27(1):6. PubMed ID: 35016612
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.
Gu SX; Tyagi T; Jain K; Gu VW; Lee SH; Hwa JM; Kwan JM; Krause DS; Lee AI; Halene S; Martin KA; Chun HJ; Hwa J
Nat Rev Cardiol; 2021 Mar; 18(3):194-209. PubMed ID: 33214651
[TBL] [Abstract][Full Text] [Related]
5. Major coagulation disorders and parameters in COVID-19 patients.
Teimury A; Khameneh MT; Khaledi EM
Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
[TBL] [Abstract][Full Text] [Related]
6. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
Hong LZ; Shou ZX; Zheng DM; Jin X
Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
[TBL] [Abstract][Full Text] [Related]
7. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
Agbuduwe C; Basu S
Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
[TBL] [Abstract][Full Text] [Related]
8. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
[TBL] [Abstract][Full Text] [Related]
9. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses.
Mackman N; Antoniak S; Wolberg AS; Kasthuri R; Key NS
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2033-2044. PubMed ID: 32657623
[TBL] [Abstract][Full Text] [Related]
10. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.
Yamada S; Asakura H
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761
[TBL] [Abstract][Full Text] [Related]
11. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic Complications of COVID-19 Infection: A Review.
Castro RA; Frishman WH
Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
[TBL] [Abstract][Full Text] [Related]
13. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system.
Lazzaroni MG; Piantoni S; Masneri S; Garrafa E; Martini G; Tincani A; Andreoli L; Franceschini F
Blood Rev; 2021 Mar; 46():100745. PubMed ID: 32868115
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.
Zadow EK; Wundersitz DWT; Hughes DL; Adams MJ; Kingsley MIC; Blacklock HA; Wu SSX; Benson AC; Dutheil F; Gordon BA
Semin Thromb Hemost; 2020 Oct; 46(7):807-814. PubMed ID: 32882720
[TBL] [Abstract][Full Text] [Related]
15. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
[TBL] [Abstract][Full Text] [Related]
16. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
17. [Peculiarities of blood coagulation disorders in patients with COVID-19].
Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
[TBL] [Abstract][Full Text] [Related]
18. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy.
Kinaneh S; Khamaysi I; Karram T; Hamoud S
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34132790
[TBL] [Abstract][Full Text] [Related]
19. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
[TBL] [Abstract][Full Text] [Related]
20. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review.
Fletcher-Sandersjöö A; Bellander BM
Thromb Res; 2020 Oct; 194():36-41. PubMed ID: 32569879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
